Valued at USD 6.26 billion in 2024, the global medical filtration market is projected to reach USD 6.67 billion in 2025 and USD 11.93 billion by 2034, growing at a CAGR of 6.7% during the forecast period 2025–2034. North America held the largest share in 2024. Key players include Asahi Kasei Corporation, Danaher, Merck KGaA, Sartorius AG and Thermo Fisher Scientific Inc.

What Medical Filtration Delivers

Medical filtration separates particles, pathogens and impurities from fluids, particularly in healthcare and laboratory settings. It helps maintain sterile environments and prevents contamination, which supports the safety and efficacy of medical treatments. It is also used in blood purification for patients with kidney failure, filtering blood to remove waste products and excess fluids.

Polysulfone & Polyethersulfone Hold the Largest Material Share

By material, the medical filtration market is divided into polysulfone & polyethersulfone, polyvinylidene fluoride, polytetrafluoroethylene, polypropylene and others. The polysulfone & polyethersulfone segment held the largest share in 2024 owing to its superior filtration properties and widespread use in critical medical processes. These materials offer high chemical resistance, thermal stability and excellent biocompatibility, making them ideal for sterilization, blood purification membranes and pharmaceutical filtration. Their ability to withstand repeated sterilization cycles without degradation has driven adoption in hospitals, laboratories and biopharmaceutical manufacturing, and the expansion of biopharmaceutical production has fueled the need for high-performance membranes that ensure sterility and purity in drug processing.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/medical-filtration-market

Ultrafiltration: The Fastest-Growing Technology

By technology, the market spans ultrafiltration, microfiltration, nanofiltration and gas filtration. Ultrafiltration is expected to grow at the fastest pace, owing to its expanding role in biotechnology, plasma separation and advanced therapeutic applications. It selectively removes viruses, endotoxins and fine particulates while preserving essential biomolecules, making it crucial for producing gene therapies and recombinant proteins. Personalized medicine and the development of biologic drugs have accelerated demand for ultrafiltration membranes in pharmaceutical and research applications. In November 2025, Nephros entered into a license and supply agreement with Medica S.p.A. covering ultrafiltration technology for medical applications.

Virus Removal Filters and Sterile Filtration

Asahi Kasei's Planova series of virus removal filters was designed to remove viruses from plasma-derived pharmaceutical products. In October 2024, the company launched Planova FG1, a next-generation virus removal filter featuring higher flux for manufacturing biotherapeutics, plasma derivatives, biosafety testing services and biopharmaceutical CDMO operations. IV infusion & sterile filtration is a defined application segment, and biopharmaceutical production often involves multiple filtration steps, including sterile filtration, to remove impurities and meet stringent regulatory standards.

Nanofiber Filtration and Sustainable Innovation

Innovations such as nanofiber filtration provide superior particle capture and antimicrobial properties. Ultra-thin fibers enhance air and liquid filtration systems, removing bacteria, viruses and particulate matter with higher efficiency. Hospitals, laboratories and pharmaceutical manufacturers are adopting nanofiber filtration to improve air quality in operating rooms, protect healthcare workers and ensure contamination-free drug production. Sustainability-focused innovation is also advancing, with manufacturers developing biodegradable and reusable filtration materials. Major players are investing heavily in research and development to expand their product portfolios, and the market is fragmented, with innovative launches, international collaborations, higher investment and mergers and acquisitions shaping competition.

Regional Strength and Competitive Profiles

North America dominated in 2024 owing to its well-established healthcare infrastructure, stringent regulatory standards and high adoption of advanced filtration technologies, with the US leading the region. Asia Pacific is estimated to grow at a rapid pace, with China expected to dominate the regional market. Asahi Kasei Corporation, founded in 1931, operates across chemicals, materials, homes, electronics and healthcare, and its medical filteration enterprises have developed blood transfusion devices, blood purification devices and critical care devices alongside virus removal technology. Thermo Fisher Scientific Inc., formed in 2006 through the merger of Thermo Electron Corporation and Fisher Scientific International, operates in over 50 countries and serves customers in more than 180 countries. Its products and services are crucial for research and development in biotechnology and pharmaceuticals, which indirectly contributes to advances in medical filtration technologies.

More Trending Latest Reports By Polaris Market Research:

singapore-malaysia-and-china-corporate-secretarial-services-market

specialty-chemicals-market

listing-the-top-10-lingerie-market-companies-globally-in-2025

semaglutide-market

titanium-dioxide-tio2-market

pet-ct-scanner-device-market

green-premium-products-market

millimeter-wave-technology-market

distributed-fiber-optic-sensor-market